Smartlab Europe

Press Releases

AbbVie, Boehringers Skyrizi yields positive results in Phase III psoriatic arthritis trials

AbbVie reported data from a pair of Phase III studies showing that Skyrizi (risankizumab) led to significantly more psoriatic arthritis patients achieving the primary endpoint of at least 20% improvement on American College of Rheumatology (ACR20) criteria than placebo...

Recipharm and Moderna finalize agreement for aseptic drug product manufacturing and fill-finish for supply to countries outside the U.S.

Moderna, Inc., biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Recipharm, a leading contract development and manufacturing organization (CDMO), announced that they have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19...

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY

Pfizer Inc. and BioNTech SE announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s...

AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK

AstraZeneca’s COVID-19 vaccine has been approved for emergency supply in the UK, with the first doses being released today so that vaccinations may begin early in the New Year. The UK Medicines and Healthcare products Regulatory Agency (MHRA) has provided...

FedEx to Ship First Wave of Moderna COVID-19 Vaccines Across the United States

FedEx Express, a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, announced that operations are in motion to transport Moderna’s COVID-19 vaccines for McKesson Corp. throughout the United States. Following the Food and Drug Administration’s...

Vir Biotechnology and GSK Announce Start of NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19

Vir Biotechnology, Inc. announced that the first patient has been dosed in a new sub-trial of the National Institutes of Health’s (NIH) Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Program Phase 3 clinical trial. This trial is designed to...

Pelican BioThermal Announces Korean Air Cargo Partnership

Pelican BioThermal, the global name in temperature controlled packaging, announces its new partnership with Korean Air Cargo, the latest in the company’s expanding network of worldwide alliances. The significant new partnership will see the Asia airline utilize Pelican BioThermal’s Cr?do™...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »